Home > Cashflow Statement > CONCORD DRUGS

CONCORD DRUGS
Cash Flow from Financing Activities

    Back to Cashflow Statement
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-1.43 Cr₹0.28 Cr₹0.62 Cr₹1.68 Cr

What is the latest Cash Flow from Financing Activities ratio of CONCORD DRUGS ?

The latest Cash Flow from Financing Activities ratio of CONCORD DRUGS is ₹-1.43 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-1.43 Cr
Mar2024₹0.28 Cr
Mar2023₹0.62 Cr
Mar2022₹1.68 Cr

How is Cash Flow from Financing Activities of CONCORD DRUGS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-1.43 Cr
Negative
Mar2024 ₹0.28 Cr
-54.65
Mar2023 ₹0.62 Cr
-62.84
Mar2022 ₹1.68 Cr -

Compare Cash Flow from Financing Activities of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹102.2 Cr 0.7% -6.1% 143.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 1.7% 6.4% 12.1% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr 3% 2.8% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 2.3% 9.1% 44.6% Stock Analytics
CIPLA ₹117,820.0 Cr 0.3% 6.1% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.1% 8.9% 1.9% Stock Analytics


CONCORD DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

0.7%

-6.1%

143.8%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses